Fig. 2

A Quantification of oxLDL removal with a fixed amount of oxLDL (60 μg) while varying the amount of added MM@Lips; B Quantification of oxLDL removal with a fixed amount of MM@Lips (0.5 mg) while varying the amount of added oxLDL; C Quantification of LPS removal with a fixed amount of LPS (50 ng) while varying the amount of added MM@Lips; D Quantification of LPS removal with a fixed amount of MM@Lips (0.5 mg) while varying the amount of added LPS; E The proportion of Oil Red O staining area in RAW264.7 cells after diferent treatments (**P < 0.01, ***P < 0.001); F Intracellular TC value of RAW264.7 cells after diferent treatments (***P < 0.001); G Western blotting was used to detect the scavenger receptor expression changes on RAW264.7 cells after different treatments (I: Control, II: oxLDL, III: SHP1i, IV: Lips-SHP1i, V: MM@Lips, VI: MM@Lips-SHP1i); H Quantification of CD36 and SRA relative expression levels (**P < 0.01, ***P < 0.001)